Comparing two antibiotics to clear C. difficile in inflammatory bowel disease
Treatments studied
Part of Digestive system, Infections clinical trials.
This study tests two antibiotics—fidaxomicin and vancomycin—to see which is better at clearing C. difficile bacteria from the gut in people with inflammatory bowel disease. If you are having a colonoscopy, you may be able to participate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have inflammatory bowel disease (Crohn's, ulcerative colitis, or indeterminate colitis).
- You must be coming in for an outpatient colonoscopy for any reason.
- You must not have had colon surgery (other than appendix removal).
- You must not be taking antibiotics on a long-term basis.
- You must be able to swallow capsules and not be allergic to the study drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking xylitol (a natural sweetener) in capsule form can help clear a harmful gut bacteria called C. difficile from people with IBD. If you have mild or inactive IBD, this might be a simple way to reduce that bacteria and potentially prevent future infections.
This trial tests whether a natural sweetener called xylitol (taken by mouth) can help reduce the amount of C. difficile bacteria in your gut, which may help prevent infection. If you have mild or inactive IBD and are planning a routine appointment, you may be able to join.
This trial compares three treatments for a severe diarrhea infection called C. diff: a fecal transplant (putting healthy donor stool into your gut), a newer antibiotic called fidaxomicin, and an older antibiotic called vancomycin. The goal is to see which works best and prevents the infection from coming back.
This trial tests whether taking vancomycin by mouth can prevent another C. diff infection when you need to take other antibiotics. It’s for patients who recently had C. diff and are about to start a new antibiotic course.
This study tests whether taking a capsule form of fecal microbiota transplant (FMT) can help adults with their first C. difficile infection—or a first relapse—get better and reduce repeat episodes. Participants also take specific antibiotics for C. difficile as part of the study process.
This study is looking at people who were treated for C. diff (a serious gut infection) at Umeå University Hospital to see how they are doing years later. It compares people who got a fecal transplant (a treatment that restores healthy gut bacteria) with those who only took antibiotics.
Hear when a new Clostridioides Difficile Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.